Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scarless hysterectomy: new vaginal surgery may cut complications for large uteri

NCT ID NCT05884658

Symptom relief Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new surgical technique called vNOTES (scarless vaginal surgery using a tiny camera) to standard laparoscopic hysterectomy in 200 women with large uteri (over 280 grams). The goal is to see if vNOTES reduces complications like infections, bleeding, or organ injury within 6 weeks after surgery. Participants are women over 18 needing a hysterectomy for non-cancer reasons. The approach may offer less pain and faster recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Any woman received in preoperative consultation in the Gynecology-Obstetrics Department for a benign pathology of a uterus estimated to be large requiring a hysterectomy. * Patient affiliated or entitled to a social security system * Patients over 18 years of age * Patients having given their agreement to participate and after signing the consent form Exclusion Criteria: * Woman refusing to participate in the study (lack of consent) * Non-French speaking woman (unable to conduct a good quality interview of the pregnant woman) * Participation in another interventional study. * Patient subject to a legal protection measure or unable to express her consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hysterectomy, vaginal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hysterectomy, vaginal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, 63003, France

  • CHU LIMOGES - Hôpital de la mère et de l'Enfant

    NOT_YET_RECRUITING

    Limoges, 87042, France

  • CHU Saint-Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, 42055, France

  • Ch Issoire

    NOT_YET_RECRUITING

    Issoire, 63500, France

  • Clinique Mutualiste de Saint-Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, 42100, France

  • HFME - Hospices Civils de Lyon

    NOT_YET_RECRUITING

    Bron, 69677, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.